Literature DB >> 31209730

The Hypermethylation of Foxp3 Promoter Impairs the Function of Treg Cells in EAP.

Jing Chen1,2,3, Changsheng Zhan1,2,3, Li Zhang1,2,3, Ligang Zhang1,2,3, Yi Liu1,2,3, Yong Zhang1,2,3, Hexi Du1,2,3, Chaozhao Liang4,5,6, Xianguo Chen7,8,9.   

Abstract

Treg cells are crucial for maintaining immune homeostasis in CP/CPPS, but the molecular mechanisms underlying the modulation of the function of Treg in CP/CPPS remain unclear. The main purpose of this study is to investigate the relationship between immunosuppressive function of Treg and the methylation level of Foxp3 promoter in experimental autoimmune prostatitis (EAP) mouse model. EAP model was induced by subcutaneous injecting prostate-steroid-binding protein (PSBP) and complete Freund's adjuvant with NOD mice. Histological analysis revealed that EAP model was successfully induced. The expression of IFN-γ was increased, and TGF-β was decreased in the serum of EAP, respectively. The percentage of Tregs in splenic lymphocyte was increased in EAP. The suppressive ability of Tregs on Teffs was impaired in EAP. The methylation level of Foxp3 promoter was increased, and the expression of Foxp3 was decreased in EAP. By injection AZA which was DNA-methylation inhibitor into EAP mice, prostate inflammation was alleviated, expressions of TGF-β and Foxp3 were increased, and the suppressive function of Tregs was improved in vitro and in vivo. Thus, we concluded that aberrant increased methylation of Foxp3 promoter in Treg cells leads to the impaired suppressive function of Treg cells, exacerbating autoimmune inflammatory injury in EAP.

Entities:  

Keywords:  CP/CPPS; EAP; Foxp3; Treg cells; methylation

Mesh:

Substances:

Year:  2019        PMID: 31209730     DOI: 10.1007/s10753-019-01030-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  42 in total

Review 1.  Complex interactions of transcription factors in mediating cytokine biology in T cells.

Authors:  Peng Li; Rosanne Spolski; Wei Liao; Warren J Leonard
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

2.  HDAC inhibitor MS-275 attenuates the inflammatory reaction in rat experimental autoimmune prostatitis.

Authors:  Zhi-Yuan Zhang; Hermann J Schluesener
Journal:  Prostate       Date:  2011-05-02       Impact factor: 4.104

3.  How common is prostatitis? A national survey of physician visits.

Authors:  M M Collins; R S Stafford; M P O'Leary; M J Barry
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

Review 4.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

5.  Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+)CD25(+) T cells in patients with autoimmune hepatitis.

Authors:  Akihiko Okumura; Tetsuya Ishikawa; Sayaka Sato; Taeko Yamauchi; Hisae Oshima; Tomohiko Ohashi; Ken Sato; Minoru Ayada; Naoki Hotta; Shinichi Kakumu
Journal:  Hepatol Res       Date:  2008-09       Impact factor: 4.288

6.  Crucial role of interferon-gamma in experimental autoimmune prostatitis.

Authors:  Ruben Darío Motrich; Evelyne van Etten; Femke Baeke; Clelia Maria Riera; Chantal Mathieu; Virginia Elena Rivero
Journal:  J Urol       Date:  2010-01-22       Impact factor: 7.450

7.  Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.

Authors:  Koen Venken; Niels Hellings; Tom Broekmans; Karen Hensen; Jean-Luc Rummens; Piet Stinissen
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

8.  The prevalence of prostatitis-like symptoms in China.

Authors:  Chao-Zhao Liang; Hong-Jun Li; Zhi-Ping Wang; Jun-Ping Xing; Wei-Lie Hu; Tao-Fu Zhang; Wei-Wei Ge; Zong-Yao Hao; Xian-Sheng Zhang; Jun Zhou; Yu Li; Zheng-Xing Zhou; Zhi-Guo Tang; Sheng Tai
Journal:  J Urol       Date:  2009-06-13       Impact factor: 7.450

9.  Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline.

Authors:  Jon Rees; Mark Abrahams; Andrew Doble; Alison Cooper
Journal:  BJU Int       Date:  2015-06-16       Impact factor: 5.588

Review 10.  Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.

Authors:  María L Breser; Florencia C Salazar; Viginia E Rivero; Rubén D Motrich
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

View more
  10 in total

1.  Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.

Authors:  Zhengyao Song; Chen Jin; Zichen Bian; Chaozhao Liang
Journal:  Mol Cell Biochem       Date:  2021-01-25       Impact factor: 3.396

2.  Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour.

Authors:  Jialin Meng; Yonghao Chen; Xiaofan Lu; Qintao Ge; Feixiang Yang; Suwen Bai; Chaozhao Liang; Juan Du
Journal:  Comput Struct Biotechnol J       Date:  2022-06-27       Impact factor: 6.155

3.  Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4+CD25+FOXP3+ Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization.

Authors:  Renyong Wang; Ruixue Li; Tiehan Li; Lei Zhu; Zongze Qi; Xiaokui Yang; Huan Wang; Baoquan Cao; Hong Zhu
Journal:  J Oncol       Date:  2022-05-26       Impact factor: 4.501

Review 4.  Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?

Authors:  Lei Chen; Meng Zhang; Chaozhao Liang
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-09-14       Impact factor: 4.291

5.  Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis.

Authors:  Meng Zhang; Yi Liu; Jing Chen; Lei Chen; Li Zhang; Xianguo Chen; Zongyao Hao; Chaozhao Liang
Journal:  J Inflamm Res       Date:  2022-04-21

6.  Immune response drives outcomes in prostate cancer: implications for immunotherapy.

Authors:  Jialin Meng; Yujie Zhou; Xiaofan Lu; Zichen Bian; Yiding Chen; Jun Zhou; Li Zhang; Zongyao Hao; Meng Zhang; Chaozhao Liang
Journal:  Mol Oncol       Date:  2020-12-29       Impact factor: 6.603

7.  Gut Microflora Modulates Th17/Treg Cell Differentiation in Experimental Autoimmune Prostatitis via the Short-Chain Fatty Acid Propionate.

Authors:  He-Xi Du; Shao-Yu Yue; Di Niu; Chang Liu; Li-Gang Zhang; Jing Chen; Yang Chen; Yu Guan; Xiao-Liang Hua; Chun Li; Xian-Guo Chen; Li Zhang; Chao-Zhao Liang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

8.  Abnormal prostate microbiota composition is associated with experimental autoimmune prostatitis complicated with depression in rats.

Authors:  Feng Liu; Xiaolin Xu; Zhong Wang; Peng Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-30       Impact factor: 6.073

9.  Peritoneal Modulators of EZH2-miR-155 Cross-Talk in Endometriosis.

Authors:  Sarah Brunty; Kristeena Ray Wright; Brenda Mitchell; Nalini Santanam
Journal:  Int J Mol Sci       Date:  2021-03-28       Impact factor: 5.923

10.  Single-cell multi-omics analysis presents the landscape of peripheral blood T-cell subsets in human chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Meng Zhang; Yi Liu; Junyi Chen; Lei Chen; Jialin Meng; Cheng Yang; Shuiping Yin; Xiansheng Zhang; Li Zhang; Zongyao Hao; Xianguo Chen; Chaozhao Liang
Journal:  J Cell Mol Med       Date:  2020-10-30       Impact factor: 5.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.